$MIBE
Miami Breeze Car Care Inc

2024 Q4 Form 10-Q Financial Statement

#000152013824000423 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $1.945K $4.701K
YoY Change -58.63%
Cost Of Revenue $793.00 $1.800K
YoY Change -55.94%
Gross Profit $1.152K $2.901K
YoY Change -60.29%
Gross Profit Margin 59.23% 61.71%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $112.4K $110.9K
YoY Change 1.42%
Operating Profit -$111.3K -$108.0K
YoY Change 3.07%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $232.00 -$2.111K
YoY Change -110.99%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$111.1K -$110.1K
YoY Change 0.89%
Net Earnings / Revenue -5710.18% -2341.78%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 33.61M shares 33.61M shares 33.47M shares
Diluted Shares Outstanding 33.61M shares 33.47M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.348K $165.8K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $7.138K
Prepaid Expenses $19.80K
Receivables
Other Receivables
Total Short-Term Assets $30.29K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.00K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $30.29K
Total Long-Term Assets $10.00K
Total Assets $40.29K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.23K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.23K
Total Long-Term Liabilities
Total Liabilities $83.23K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$3.766M
YoY Change
Common Stock $3.361K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$42.94K $382.9K
YoY Change
Total Liabilities & Shareholders Equity $40.29K
YoY Change

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$111.1K -$110.1K
YoY Change 0.89%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001872066
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 us-gaap Assets
Assets
40286 usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23809 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3347 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3603676 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3431085 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
176038 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
199847 usd
us-gaap Revenues
Revenues
5897 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
793 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
dei Entity Registrant Name
EntityRegistrantName
MIAMI BREEZE CAR CARE INC.
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33606966 shares
CY2023Q4 us-gaap Cash
Cash
74889 usd
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
10000 usd
CY2023Q4 us-gaap Assets
Assets
199847 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
66600 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
83227 usd
CY2024Q3 us-gaap Liabilities
Liabilities
83227 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33471966 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3766064 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-42941 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40286 usd
CY2024Q3 us-gaap Revenues
Revenues
1945 usd
CY2023Q3 us-gaap Revenues
Revenues
4701 usd
us-gaap Revenues
Revenues
14747 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1800 usd
us-gaap Cost Of Revenue
CostOfRevenue
2703 usd
us-gaap Cost Of Revenue
CostOfRevenue
6293 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1152 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2901 usd
us-gaap Gross Profit
GrossProfit
3194 usd
us-gaap Gross Profit
GrossProfit
8454 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
54648 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
708 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3599 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3536 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
14655 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
35296 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
26705 usd
us-gaap Professional Fees
ProfessionalFees
125373 usd
us-gaap Professional Fees
ProfessionalFees
410181 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7415 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11223 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22270 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32102 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Payments For Delayed Tax Exempt Exchange
PaymentsForDelayedTaxExemptExchange
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
mibe Proceeds From Sale Of Common Stock Yet To Be Issued
ProceedsFromSaleOfCommonStockYetToBeIssued
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-266854
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2579086
dei Entity Address Address Line1
EntityAddressAddressLine1
848 Brickell Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
PH 5
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33131
dei City Area Code
CityAreaCode
786
dei Local Phone Number
LocalPhoneNumber
743-3017
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash
Cash
3348 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
7138 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
103933 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1300 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
155 usd
CY2024Q3 mibe Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
18500 usd
CY2023Q4 mibe Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
20870 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
30286 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
199847 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16627 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23809 usd
CY2023Q4 us-gaap Liabilities
Liabilities
23809 usd
CY2024Q3 mibe Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 mibe Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33606966 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33606966 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33471966 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3361 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3719662 usd
CY2024Q3 mibe Stockbased Professional Fees
StockbasedProfessionalFees
20000 usd
CY2023Q3 mibe Stockbased Professional Fees
StockbasedProfessionalFees
0 usd
mibe Stockbased Professional Fees
StockbasedProfessionalFees
70000 usd
mibe Stockbased Professional Fees
StockbasedProfessionalFees
363426 usd
CY2024Q3 mibe Professional Fees Related Party
ProfessionalFeesRelatedParty
54870 usd
CY2023Q3 mibe Professional Fees Related Party
ProfessionalFeesRelatedParty
51350 usd
mibe Professional Fees Related Party
ProfessionalFeesRelatedParty
172370 usd
mibe Professional Fees Related Party
ProfessionalFeesRelatedParty
138350 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
112447 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
110877 usd
us-gaap Operating Expenses
OperatingExpenses
337707 usd
us-gaap Operating Expenses
OperatingExpenses
649936 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-111295 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-107976 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-334513 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-641482 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
232 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2111 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-466 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2585 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
232 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2111 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-466 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2585 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-111063 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-110087 usd
us-gaap Profit Loss
ProfitLoss
-334979 usd
us-gaap Profit Loss
ProfitLoss
-644067 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33606966 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33606966 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33471966 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33471966 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33580725 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33580725 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33471966 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33471966 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
176038 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-127417 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164621 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-96499 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
68122 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-111063 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-42941 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1026950 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-356830 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
670120 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-177150 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
492970 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-110087 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
382883 usd
us-gaap Profit Loss
ProfitLoss
-334979 usd
us-gaap Profit Loss
ProfitLoss
-644067 usd
mibe Stockbased Professional Fees
StockbasedProfessionalFees
70000 usd
mibe Stockbased Professional Fees
StockbasedProfessionalFees
363426 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
14158 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9137 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4094 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17355 usd
mibe Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
-2370 usd
mibe Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
18499 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
47818 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6342 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-174141 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-296892 usd
us-gaap Payments For Delayed Tax Exempt Exchange
PaymentsForDelayedTaxExemptExchange
10000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
76000 usd
mibe Proceeds From Sale Of Common Stock Yet To Be Issued
ProceedsFromSaleOfCommonStockYetToBeIssued
36600 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
102600 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-71541 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-296892 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74889 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
462729 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3348 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165837 usd
us-gaap Profit Loss
ProfitLoss
-334979 usd
us-gaap Profit Loss
ProfitLoss
-644067 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3766064 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3431085 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-174141 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-296892 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zlBishENYcgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zXuqrI6k5nx5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the nine months ended September 30, 2024 and 2023 include estimates for obsolete or slow-moving inventory and the fair value of non-cash equity transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
7138 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
103933 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19800 usd
CY2024Q3 mibe Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
18500 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21025 usd
CY2023Q4 mibe Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
20870 usd
us-gaap Advertising Expense
AdvertisingExpense
3536 usd
us-gaap Advertising Expense
AdvertisingExpense
14655 usd
CY2024Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2024Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 mibe Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 mibe Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
95000 shares
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
76000 usd
CY2024Q1 us-gaap Share Price
SharePrice
0.80
CY2024Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
33250 shares
CY2024Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
26600 usd
CY2024Q2 us-gaap Share Price
SharePrice
0.80
CY2024Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
10000 shares
CY2024Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10000 usd
CY2024Q3 us-gaap Share Price
SharePrice
1.00
CY2024Q3 mibe Shares To Be Issues
SharesToBeIssues
73250 shares
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14158 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001520138-24-000423-index-headers.html Edgar Link pending
0001520138-24-000423-index.html Edgar Link pending
0001520138-24-000423.txt Edgar Link pending
0001520138-24-000423-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
miami-20240930_10q.htm Edgar Link pending
miami-20240930_10qex31z1.htm Edgar Link pending
miami-20240930_10qex31z2.htm Edgar Link pending
miami-20240930_10qex32z1.htm Edgar Link pending
mibe-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mibe-20240930_cal.xml Edgar Link unprocessable
mibe-20240930_def.xml Edgar Link unprocessable
mibe-20240930_lab.xml Edgar Link unprocessable
miami-20240930_10q_htm.xml Edgar Link completed
mibe-20240930_pre.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending